1. CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
   Naoki Kawahara et al, 2021, International Journal of Molecular Sciences CrossRef
2. Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer
   Sana D. Karam et al, 2018, Clinical Cancer Research CrossRef
3. A Small Compound KJ-28d Enhances the Sensitivity of Non-Small Cell Lung Cancer to Radio- and Chemotherapy
   Hwani Ryu et al, 2019, International Journal of Molecular Sciences CrossRef
4. Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer
   Patrycja Gralewska et al, 2020, Journal of Hematology & Oncology CrossRef
5. Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical characterization
   Navnath P. Karche et al, 2020, Bioorganic & Medicinal Chemistry CrossRef
6. The HNF-1β―USP28―Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma
   Fuminori Ito et al, 2018, Oncotarget CrossRef
7. Cutting-Edge Technologies for Ovarian Cancer: An Overview of the Impact of Genetic Testing, Next-Generation Sequencing, and Single-Cell Analysis
   Alia Ghoneum et al, 2021, Ovarian Cancer Biomarkers CrossRef
8. Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic Cancer
   Aditi Jain et al, 2019, Cancer Research CrossRef
9. Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway
   Entaz Bahar et al, 2021, International Journal of Molecular Sciences CrossRef
10. Epigenetic based synthetic lethal strategies in human cancers
    Aiai Gao et al, 2020, Biomarker Research CrossRef
11. PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness
    Patrycja Gralewska et al, 2020, International Journal of Molecular Sciences CrossRef
12. Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis
    Robert Beaumont Wilson, 2018, Pleura and Peritoneum CrossRef
13. Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action
    David G. Covell et al, 2021, PLOS ONE CrossRef
14. PARP Inhibitor Olaparib Causes No Potentiation of the Bleomycin Effect in VERO Cells, Even in the Presence of Pooled ATM, DNA-PK, and LigIV Inhibitors
    Valentina Perini et al, 2020, International Journal of Molecular Sciences CrossRef